Industry Professionals, Politicians, Parents and Media to Showcase Best Practices and Testimonials
SAN DIEGO, May 30, 2014 (GLOBE NEWSWIRE) — Don’t look now, but there’s hemp blowing in the air in the “Windy City.”
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=25646
HempMeds™ is rolling into “Chi-town” as the platinum sponsor of the Chicago Cannabis Conference to be held at Navy Pier June 7-8. The Chicago Cannabis Conference is hosted by MyCompassion.org, a nonprofit whose goal is increasing awareness of medical cannabis best practices to 9.8 million people in the Chicago Metro area. As a result of Illinois passing the Illinois Compassionate Medical Cannabis Act, conference presentations will feature cannabis industry professionals, non-profit organizations, medical professionals, lawmakers, and professional athletes plus patient and parent advocates.
“We are honored to be the platinum sponsor of the inaugural Chicago Cannabis Conference,” HempMeds™ Director of Public Relations Andrew Hard said. “With the passing of the Illinois Compassionate Medical Cannabis Act, there is a need for mass education on the cannabis industry, what is available to consumers and what impact the new regulations have on their lives. HempMeds™ is thrilled to have the opportunity to continue our awareness campaign of ‘DON’T MOVE’ and the ability to educate thousands that CBD-rich hemp oil products are available in all 50 states. HempMeds is looking forward to contributing to the discussion at the Chicago Cannabis Conference.”
Interested conference-goers that want to check out HempMeds products and learn more should stop by the HempMeds booth located at C1.
“We are very excited to welcome HempMeds™ as the platinum sponsor of the Chicago Cannabis Conference,” Heidi Parikh, Founder and President of My Compassion, said. “Their dedication to helping others and the professionalism they reflect in the cannabis/hemp industry is top notch.”
For more information on the conference or to register, visit http://chicagocannabisconference.com or http://mycompassion.org.
For more information on CBD-rich hemp oil products, please visit:
Real Scientific Hemp Oil™
The Company invites the public to get involved in the conversation about CBD-rich hemp oil as it relates to HempMeds™ through the Company’s social media websites on Facebook and Twitter.
HempMeds offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds is the largest CBD-rich hemp oil distributor in the U.S. and the only source of CBD-rich hemp oil that is currently available in all 50 states.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
HempMeds does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). Cannabidiol is a natural constituent of hemp oil.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
For further information, please contact:
Director of PR, HempMeds
This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.